What does high blood sugar have to do with vulnerability to COVID-19? And is there a role for the controversial drug hydroxychloroquine in lowering blood sugar in COVID-19 patients?
Academic rigor, journalistic flair
Articles on ACE2
Displaying 21 - 22 of 22 articles
Some things about COVID-19 still don’t add up.
Top contributors
-
Professor of Medicine, University of Virginia
-
Senior Lecturer in Chemical Pathology, University of Westminster
-
Assistant Professor/Canada Research Chair in emerging viruses, University of Manitoba
-
Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Associate Professor in Viral Immunology, University of Birmingham
-
Professor of Medicine, University of Pittsburgh
-
Professor of Pharmacology and Medicine, University of California, San Diego
-
Professor of Medicine, University of California, San Diego
-
Postdoctoral Fellow, University of California, San Diego
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
PhD en Sciences Pharmaceutiques, Université de Montréal
-
Consultant Rhinologist and ENT surgeon, City, University of London
-
Professor of Medicine and Director, Center for Antibody Therapeutics, University of Pittsburgh
-
Professor of Respiratory Medicine, Swansea University
